Ephedra
Revision as of 00:16, 29 January 2010 by Steven Harkins (talk | contribs)
A systematic review of 117 studies found that ephedra and ephedrine promoted modest shortter weight loss (approximately 0.9 kg/month more than with placebo) but increased the risk of psychiatric, autonomic, gastrointestinal, and cardiac complications by a factor of 2.2 to 3.6. Cite error: Closing </ref> missing for <ref> tag
